We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$608M
AUM Growth
-$455M
Cap. Flow
-$486M
Cap. Flow %
-79.89%
Top 10 Hldgs %
19.27%
Holding
429
New
65
Increased
103
Reduced
150
Closed
81

Top Buys

Rank Stock Value
1
MMS icon
Maximus
MMS
+$9M
2
ESGR
Enstar Group
ESGR
+$3.12M
3
SYM icon
Symbotic
SYM
+$2.62M
4
MLR icon
Miller Industries
MLR
+$2.62M
5
PD icon
PagerDuty
PD
+$2.45M

Top Sells

Rank Stock Value
1
FANG icon
Diamondback Energy
FANG
+$67.9M
2
OVV icon
Ovintiv
OVV
+$64.5M
3
ERF
Enerplus Corporation
ERF
+$61.9M
4
SM icon
SM Energy
SM
+$48.8M
5
DEN
Denbury Inc.
DEN
+$33.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.7%
2 Technology 16.95%
3 Industrials 13.89%
4 Financials 13.4%
5 Healthcare 12.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
101
Johnson & Johnson
JNJ
$635B
$1.51M 0.25%
9,745
+13
+0.1% +$2.1K
TRN icon
102
Trinity Industries
TRN
$2.97B
$1.5M 0.25%
61,632
-1,405
-2% -$37.3K
ARCC icon
103
Ares Capital
ARCC
$13.5B
$1.49M 0.25%
81,565
+5
+0% +$95
CVCO icon
104
Cavco Industries
CVCO
$4.39B
$1.49M 0.24%
4,675
+2,409
+106% +$667K
CVX icon
105
Chevron
CVX
$388B
$1.48M 0.24%
9,083
LRCX icon
106
Lam Research
LRCX
$382B
$1.47M 0.24%
27,720
+150
+0.5% +$7.36K
RSP icon
107
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$1.46M 0.24%
10,118
-2,245
-18% -$329K
HQY icon
108
HealthEquity
HQY
$7.91B
$1.45M 0.24%
24,770
-365
-1% -$22.2K
VET icon
109
Vermilion Energy
VET
$1.73B
$1.43M 0.24%
110,566
-3,513
-3% -$49.5K
VEA icon
110
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.39M 0.23%
30,809
TJX icon
111
TJX Companies
TJX
$170B
$1.36M 0.22%
17,400
-39
-0.2% -$3.07K
LFST icon
112
Lifestance Health
LFST
$4.16B
$1.36M 0.22%
+182,788
New +$1.01M
DCBO
113
Docebo
DCBO
$492M
$1.34M 0.22%
32,784
-577
-2% -$21.2K
INSE icon
114
Inspired Entertainment
INSE
$177M
$1.33M 0.22%
104,085
+19,695
+23% +$284K
AXP icon
115
American Express
AXP
$223B
$1.33M 0.22%
8,062
PRVA icon
116
Privia Health
PRVA
$3.21B
$1.33M 0.22%
48,041
-6,892
-13% -$182K
AIN icon
117
Albany International
AIN
$2.14B
$1.25M 0.21%
14,004
-5,845
-29% -$590K
ABT icon
118
Abbott
ABT
$180B
$1.24M 0.2%
12,250
ASO icon
119
Academy Sports + Outdoors
ASO
$2.89B
$1.24M 0.2%
18,957
-94
-0.5% -$5.54K
VRAY
120
DELISTED
ViewRay, Inc.
VRAY
$1.22M 0.2%
353,100
-95,756
-21% -$405K
LHX icon
121
L3Harris
LHX
$55.9B
$1.21M 0.2%
6,183
-5,596
-48% -$1.14M
TSLX icon
122
Sixth Street Specialty
TSLX
$1.59B
$1.21M 0.2%
66,152
+3,957
+6% +$73.4K
DOL icon
123
WisdomTree True Developed International Fund
DOL
$813M
$1.21M 0.2%
25,850
TMO icon
124
Thermo Fisher Scientific
TMO
$211B
$1.2M 0.2%
2,077
+29
+1% +$16.3K
AAON icon
125
Aaon
AAON
$8.41B
$1.19M 0.2%
18,435
+10,566
+134% +$581K

Similar funds

Advisory Research's Q1 2023 Portfolio in Review

As of Q1 2023, Advisory Research held 429 positions worth $608M, down 43% from $1.06B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Advisory Research withdrew a net $486M in Q1 2023, closing 81 positions and reducing 150 holdings. Its most notable exit was Ovintiv, an estimated $64.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 8.6% a quarter earlier, followed by Technology and Industrials.

Against the trend, Advisory Research opened a new position in Maximus worth $9.19M.

  • Advisory Research's largest Q1 2023 buy was Maximus: 116,828 shares worth $9.19M.
  • Advisory Research added most to Enstar Group in Q1 2023, an estimated $3.12M increase.
  • Advisory Research's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $67.9M.
  • Advisory Research fully exited Ovintiv in Q1 2023, selling an estimated $64.5M.
  • Advisory Research's ten largest holdings make up 19% of its $608M portfolio in Q1 2023.
  • Advisory Research opened 65 new positions and closed 81 in Q1 2023.
  • Advisory Research's portfolio value fell 43% quarter-over-quarter to $608M.

Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.